Cantat et al.
immediately red, was stirred for 30 min, and filtered through a
Celite-padded coarse frit. The filtrate was collected, and the volatiles
were removed under reduced pressure to give [(PNP)UCl3]2 (8) as
Ph3P)O), 1160.1 (br s, PNP). Anal. Calcd for C44H55Cl3NOP3U
(mol. wt. 1051.22): C, 50.27; H, 5.27; N, 1.33. Found: C, 49.96;
H, 5.31; N, 1.30.
1
Synthesis of (PNP)2UI (12). A 50 mL sidearm flask equipped
with a stir bar was charged with UI3(THF)4 (930 mg, 1.03 mmol,
1.0 equiv) and THF (10 mL). To the resulting mixture was added
a solution of (PNP)K (6) (963 mg, 2.06 mmol, 2.0 equiv) in THF
(10 mL) at ambient temperature. The reaction mixture turned
immediately green, was stirred for 2 days, and filtered through a
Celite-padded coarse frit. The filtrate was collected, the volatiles
were removed under reduced pressure, and the resulting dark green
solid was washed with 10 mL of cold (-35 °C) hexane to give
(PNP)2UI (13) as a dark green solid (1.22 g, 1.00 mmol, 97%).
X-ray quality samples of 13 were obtained by recrystallization from
a red solid (1.62 g, 1.05 mmol, 98%). H NMR (C6D6, 298 K): δ
-26.40 (s, 6H), -19.99 (s, 6H), -9.66 (s, 2H), -8.53 (s, 6H),
-1.47 (s, 2H), 1.09 (s, 6H), 4.40 (s, 2H), 6.91 (s, 6H), 21.45 (s,
2H), 43.57 (s, 2H). 31P{1H} NMR (C6D6, 298 K): δ 1157.3 (br s).
Anal. Calcd for C52H80Cl6N2P4U2 (mol. wt. 1542.44): C, 40.40; H,
5.22; N, 1.81. Found: C, 40.39; H, 5.62; N, 2.0.
Characterization of (PNP)UCl3(THF) (9). Complex 9 is formed
in equilibrium with 8 (52/48 ratio at 25 °C in THF-d8) upon
dissolution of 8 in THF. Crystals of 9 were obtained by cooling a
concentrated solution of 8 in THF at -35 °C. Upon drying under
reduced pressure, crystals of 9 resort to pure 8. 1H NMR (THF-d8,
298 K): δ -23.62 (s, 6H), -19.20 (s, 6H), -9.35 (s, 2H), -6.77
(s, 6H), -6.16 (s, 2H), -3.21 (s, 2H), 0.16 (s, 6H), 5.54 (s, 6H),
19.03 (s, 2H), 38.04 (s, 2H). 31P{1H} NMR (THF-d8, 298 K): δ
1151.2 (s).
1
hexane at -35 °C. H NMR (THF-d8, 273 K): δ -39.92(s, 1H),
-32.96 (s, 1H), -31.53 (s, 3H), -28.45 (s, 6H), -25.21 (s, 3H),
-22.70 (s, 3H), -21.05 (s, 1H), -16.16 (s, 6H), -13.17 (s, 3H),
-9.27 (s, 1H), -6.34 (s, 3H), -5.94 (s, 3H), -5.66 (s, 3H), -2.30
(s, 3H), -1.73 (s, 6H), 3.04 (s, 3H), 5.63 (s, 1H), 6.29 (s, 1H),
6.47 (s, 1H), 8.11 (s, 6H), 10.13 (s, 3H), 10.88 (s, 1H), 11.11 (s,
1H), 11.34 (s, 3H), 13.73 (s, 1H), 14.07 (s, 1H), 15.67 (s, 1H),
16.85 (s, 1H), 18.88 (s, 1H) 26.85 (s, 1H), 30.38 (s, 3H), 34.14 (s,
1H), 38.75 (s, 1H), 56.41 (s, 1H), 68.12 (s, 1H), 96.80 (s, 1H).
31P{1H} NMR (THF-d8, 298 K): no signal observed in the range
(5000 ppm. Anal. Calcd for C52H80IN2P4U (mol. wt. 1222.03): C,
51.11; H, 6.60; N, 2.29. Found: C, 50.80; H, 6.84; N, 2.15.
Synthesis of (PNP)2UCl2 (13). A 50 mL sidearm flask equipped
with a stir bar was charged with UCl4 (391 mg, 1.03 mmol, 1.0
equiv) and THF (10 mL). To the resulting suspension was added
a solution of (PNP)K (6) (963 mg, 2.06 mmol, 2.0 equiv) in THF
(10 mL) at ambient temperature. The reaction mixture turned
immediately red, was stirred for 2 days, and then concentrated to
10 mL. Pentane (10 mL) was added, and the solution was filtered
through a Celite-padded coarse frit. The filtrate was collected, and
volatiles were removed under reduced pressure to give (PNP)2UCl2
(12) as a red solid (1.19 g, 1.02 mmol, 99%). X-ray quality samples
of 12 were obtained by recrystallization from a mixture of THF
Synthesis of (PNP)UCl3(TMPO)2 (10). A 50 mL sidearm flask
equipped with a stir bar was charged with UCl4 (812 mg, 2.14
mmol, 1.0 equiv) and THF (10 mL). To the resulting suspension
was added a solution of (PNP)K (6) (1.00 g, 2.14 mmol, 1.0 equiv)
in THF (10 mL) at ambient temperature. The reaction mixture
turned immediately red, was stirred for 30 min, and filtered through
a Celite-padded coarse frit. The filtrate was collected, trimeth-
ylphosphine oxide (TMPO, 394 mg, 4.28 mmol, 2.0 equiv) was
added as a solid, and the resulting solution was stirred for 10 min.
The volatiles were removed under reduced pressure to give
(PNP)UCl3(TMPO)2 (10) as a red solid (2.01 g, 2.10 mmol, 98%).
X-ray quality samples of 10 were obtained by recrystallization from
THF and TMS2O at -35 °C. 1H NMR (THF-d8, 323 K): δ -19.75
(s, 6H), -17.29 (s, 6H), -10.63 (s, 2H), -7.15 (s, 2H), -5.04 (s,
6H), -0.14 (s, 6H), 2.94 (s, 2H), 4.86 (s, 6H), 13.62 (s, 18H,
Me3P)O), 17.63 (s, 2H), 34.80 (s, 2H). 31P{1H} NMR (THF-d8,
323 K): δ 80.5 (s, Me3P)O), 1057.9 (br s, PNP). 1H NMR (THF-
d8, 223 K): δ -43.29 (s, 3H), -37.78 (s, 3H), -29.59 (s, 3H),
-25.99 (s, 3H), -24.27 (s, 1H), -19.57 (s, 1H), -17.87 (s, 1H),
-10.97 (s, 1H), -10.25 (s, 3H), -8.01 (s, 1H), -6.41 (s, 1H),
0.15 (s, 3H), 2.29 (s, 9H, Me3P)O), 2.85 (s, 3H), 6.88 (s, 3H),
7.13 (s, 3H), 17.15 (s, 1H), 19.94 (s, 3H), 26.68 (s, 1H), 33.12 (s,
9H, Me3P)O), 34.15 (s, 1H), 57.49 (s, 1H). 31P{1H} NMR (THF-
d8, 223 K): δ 85.3 (s, Me3P)O), 157.4 (s, Me3P)O), 1277.9 (br s,
PNP). Anal. Calcd for C32H58Cl3NO2P4U (mol. wt. 957.09): C,
40.16; H, 6.11; N, 1.46. Found: C, 40.21; H, 5.97; N, 1.31.
Synthesis of (PNP)UCl3(TPPO) (11). A 50 mL sidearm flask
equipped with a stir bar was charged with UCl4 (812 mg, 2.14
mmol, 1.0 equiv) and THF (10 mL). To the resulting suspension
was added a solution of (PNP)K (6) (1.00 g, 2.14 mmol, 1.0 equiv)
in THF (10 mL) at ambient temperature. The reaction mixture
turned immediately red, was stirred for 30 min, and filtered through
a Celite-padded coarse frit. The filtrate was collected, triph-
enylphosphine oxide (TPPO, 595 mg, 2.14 mmol, 1.0 equiv) was
added as a solid, and the resulting solution was stirred for 10 min.
The volatiles were removed under reduced pressure, and the
resulting red solid was washed with 10 mL of pentane to give
(PNP)UCl3(TPPO) (11) as a red solid (2.21 g, 2.10 mmol, 98%).
1H NMR (C6D6, 298 K): δ -23.72 (s, 6H), -20.42 (s, 6H), -13.04
(s, 2H), -8.17 (s, 2H), -6.59 (s, 6H), -1.57 (s, 6H), 4.79 (s, 2H),
6.58 (s, 6H), 9.47 (s, 3H), 10.07 (s, 6H), 21.30 (s, 2H), 23.82 (s,
6H), 44.89 (s, 2H). 31P{1H} NMR (C6D6, 298 K): δ 127.4 (s,
1
and TMS2O at -35 °C. H NMR (THF-d8, 323 K): δ -35.43 (s,
6H), -21.34 (s, 6H), -19.99 (s, 2H), -7.68 (s, 2H), -4.83 (s,
2H), -2.48 (s, 6H), 4.68 (s, 6H), 5.70 (s, 6H), 6.61 (s, 12H), 7.83
(s, 6H), 9.03 (s, 2H), 9.24 (s, 6H), 10.36 (s, 2H), 11.69 (s, 6H),
13.33 (s, 2H), 14.80 (s, 2H), 17.15 (s, 2H), 41.21 (s, 2H), 49.46 (s,
1
2H). 31P{1H} NMR (THF-d8, 323 K): δ 56.1 (s), 1469.3 (s). H
NMR (THF-d8, 223 K): δ -57.79 (s, 6H), -54.15 (s, 2H), -51.31
(s, 6H), -40.12 (s, 2H), -29.54 (s, 6H), -22.81 (s, 2H), -17.74
(s, 6H), -15.12 (s, 6H), -3.49 (s, 6H), -2.88 (s, 6H), 2.19 (s,
2H), 6.57 (s, 6H), 13.81 (s, 2H), 17.24 (s, 6H), 25.20 (s, 2H), 42.91
(s, 6H), 45.90 (s, 2H), 60.66 (s, 2H), 108.43 (s, 2H), 141.20 (s,
2H). 31P{1H} NMR (THF-d8, 223 K): δ 50.3 (s), 1401.1 (s). Anal.
Calcd for C52H80IN2P4U (mol. wt. 1166.03): C, 53.26; H, 6.92; N,
2.40. Found: C, 53.23; H, 7.04; N, 2.29.
Results and Discussion
Synthesis of Mono(PNP) Uranium(III)/(IV) Complexes.
A major reason for the success of the pentamethylcyclopen-
tadienyl ligand in organometallic uranium chemistry is due
to its ability to stabilize uranium in a wide range (III, IV, V,
and VI) of oxidation states.15 This entire body of chemistry
relies on the low-valent uranium(III) and uranium(IV) halide
complexes as starting materials shown in Chart 2, namely,
the mono(C5Me5) complexes 1-2 and the bis(C5Me5)
complexes 3-4. To develop a new and versatile platform
2118 Inorganic Chemistry, Vol. 48, No. 5, 2009